Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis
Trial ID or NCT#
Status
Purpose
A pilot study to assess the safety, feasibility, and potential (uncontrolled) efficacy of continuous glucose monitoring (CGMS) in conjunction with an insulin pump to improve glycemic control for treatment of type 1 and type 2 diabetic patients with gastroparesis
Official Title
Pilot Study of the Safety, Feasibility, and Potential Efficacy of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)
Eligibility Criteria
- * Age 18 - 70 years old at registration* Type 1 or Type 2 diabetes mellitus for at least 2 years* Symptoms of gastroparesis (nausea, vomiting, early satiety, bloating, fullness, discomfort) for at least 1 year prior to registration* Gastroparesis Cardinal Symptom Index (GCSI) score of 18* Delayed gastric emptying on gastric scintigraphy within 1 year of registration, defined as greater than 60% retention at 2 hours or greater than 10% retention at 4 hours* Hemoglobin A1c of at least 8.0% at registration regardless of current therapy. Individuals already receiving diabetes therapy via an insulin pump will be eligible for study participation if, in the opinion of the investigators, he/she may acquire additional benefit from continuous glucose monitoring that might improve glycemic control* Normal upper endoscopy within 1 year of registration* No clinical or imaging evidence of obstruction* Successful mastering of use of CGMS during the run-in period
- * Prior gastric surgery including fundoplication* Other systemic disease potentially causative of gastrointestinal symptoms* Acute or chronic renal insufficiency with creatinine \>1.5 mg/dL* Psychiatric disease or eating disorder* Pregnancy* Any other condition which, in the opinion of the investigators, would impede compliance or hinder completion of the study
Investigator(s)
View on ClinicalTrials.gov